Janus kinase (JAK) and signal transducer activator of transcription (STAT) play a unique role in various disease states. Consequently, JAK inhibitors are important as therapeutics. They are being tested or used in myeloproliferative neoplasms, rheumatoid arthritis, inflammatory bowel disease, and several immune-related dermatological diseases
JAK inhibitors are approved against rheumatism, chronic IBD, myeloproliferative neoplasias, and psoriasis.
see also:
[Janus fa…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!